Healthcare Foresights has released a new report on the global generative AI in clinical trials market, pointing to steady growth over the next decade. According to the study, the market was valued at about USD 0.74 billion in 2025 and is expected to reach roughly USD 1.86 billion by 2035.
The forecast implies a compound annual growth rate of 9.63%, highlighting rising commercial interest in generative AI tools used across clinical research workflows. While the trimmed release does not provide full methodological detail, the report positions the segment as an expanding part of the broader healthcare AI market.
Based on the title and summary, the research covers market size, share, trends, outlook, growth rate and value, along with segmentation and competitive leadership analysis. It also indicates that the report includes a SWOT-style review, suggesting a focus on both the opportunities and constraints shaping adoption in clinical trial settings.
The publication was announced from Austin, Texas, on August 5, 2026, through GlobeNewswire. With generative AI drawing more attention in healthcare operations and research, the report frames clinical trials as a key area where vendors, investors and industry planners are tracking long-term market potential.
